Charise Gleason, MSN, NP-C, AOCNP, Kathryn Maples, PharmD, BCOP, and Chelsea Sprouse, FNP-C discuss their approach to the care of transplant-eligible patients with multiple myeloma, particularly based on the patients' risk stratification, as well as poor-prognosis cytogenetics including those with (4,14) translocation.
Standard of Care Therapy for Transplant Eligible Patients with Multiple Myeloma Based on Risk Stratification
Video Library —April 22, 2020
Categories:
Interview with the InnovatorsAdvanced Practice Provider Chief, Winship Cancer Institute,
Emory University,
Atlanta, GA
Emory University,
Atlanta, GA
Clinical Pharmacy Specialist, Multiple Myeloma, and PGY2 Oncology Residency Research Coordinator,
Winship Cancer Institute, Emory Healthcare,
Atlanta, GA
Winship Cancer Institute, Emory Healthcare,
Atlanta, GA
Nurse Practitioner, Inpatient and Outpatient Malignant Hematology,
Levine Cancer Institute,
Charlotte, NC
Levine Cancer Institute,
Charlotte, NC
Last modified: August 10, 2023